Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.9
12.7 %
$ 11.7 M
Market Cap
1.06
P/E
CASH FLOW STATEMENT
30.8 M
OPERATING CASH FLOW
0
INVESTING CASH FLOW
0
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Eagle Pharmaceuticals, Inc.
| Net Income | -2.67 M |
| Depreciation & Amortization | 16.7 M |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 0 |
| Change in Working Capital | 866 K |
| Others | -14 M |
| Free Cash Flow | 30.8 M |
Cash Flow
Millions
| Mar-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Sep-2014 | Sep-2013 | Sep-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (2.7) | 35.6 | (8.6) | 12.0 | 14.3 | 31.9 | 51.9 | 81.5 | 2.6 | (18.0) | (6.0) | (19.4) |
| Depreciation & Amortization | 16.7 | 12.0 | 3.8 | 4.8 | 4.7 | 3.7 | 3.7 | 1.6 | 0.1 | 0.1 | 0.1 | 0.2 |
| Deferred Income Tax | 29.9 | (8.3) | (3.6) | (1.5) | 0.2 | (2.5) | 17.3 | (30.1) | (3.8) | 0 | 1.1 | 51 K |
| Stock Based Compensation | 0 | 16.5 | 19.6 | 24.8 | 22.0 | 19.1 | 15.4 | 9.8 | 4.1 | 0.6 | 0.3 | 0.4 |
| Other Operating Activities | (14.0) | 11.3 | 7.6 | 8.7 | 0.5 | 8.1 | 80 K | (0.8) | 4.1 | 0.6 | 1.5 | 0.3 |
| Change in Working Capital | 0.9 | (16.4) | 9.5 | 0.8 | 14.4 | (7.9) | (29.6) | (8.7) | (16.7) | 2.9 | (2.8) | 2.8 |
| Cash From Operations | 30.8 | 50.7 | 28.2 | 49.5 | 56.0 | 52.4 | 58.9 | 53.2 | (9.7) | (13.8) | (5.9) | (15.5) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | 0 | (0.2) | (0.3) | (0.7) | (0.8) | (0.1) | (5.2) | (20.7) | (1.9) | 46 K | 40.5 K | 33 K |
| Other Items | 0 | (86.7) | (5.0) | (17.5) | 0 | 0 | 0 | (25.1) | 0 | (20.0) | 1.5 | 3.0 |
| Cash From Investing Activities | 0 | (86.8) | (5.3) | (18.2) | (0.8) | (0.1) | (5.2) | (45.8) | (1.9) | (20.0) | 1.5 | 3.0 |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | (18.0) | (21.2) | (35.0) | (18.0) | (73.1) | (43.8) | (37.0) | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 12.8 | (8.0) | (5.0) | (6.0) | (3.8) | 48.8 | 0 | 0 | 0 | 0 | 9.7 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (1.0) | 0.8 | 2.1 | (0.3) | (11.3) | 3.1 | 3.3 | 1.5 | 85 K | 9.8 | (0.1) |
| Cash From Financing Activities | 0 | (6.2) | (28.4) | (37.9) | (24.2) | (88.1) | 8.1 | (33.7) | 55.8 | 46.2 | 9.8 | 9.5 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | 30.8 | (42.3) | (5.5) | (6.6) | 31.0 | (35.9) | 61.8 | (26.3) | 44.2 | 12.3 | 5.4 | (3.0) |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | 30.8 | 50.5 | 27.9 | 48.8 | 55.2 | 52.3 | 53.7 | 32.5 | (11.6) | (13.9) | (5.9) | (15.6) |